|
The Cochrane Collaboration
Cochrane Reviews |
|
|
For complete list (no sub-topics), click here - Browse by sub-topic (Review Group)
Multiple Sclerosis Group
(33)
Treatment (Pharmacological Interventions) (16)
Biologics (2)
Alemtuzumab (0)
Daclizumab (1)
Daclizumab for relapsing remitting multiple sclerosis (protocol stage)
Natalizumab (1)
Natalizumab for relapsing remitting multiple sclerosis (protocol stage)
Rituximab (0)
T-cell vaccination (0)
Immunosuppressants (4)
Bone Marrow Transpantation (0)
Cladribine (0)
Cyclosporin A (0)
Total Lymphoid Irradiation (0)
Immunotherapies (6)
Interferons: recombinant alpha-2a, recombinant beta-1a and beta-1b (4)
Interferon beta for secondary progressive multiple sclerosis (protocol stage)
Interleukine(s) (0)
Plasma Exchange (0)
Non steroidal Anti-inflammatory Drugs (NSAIDS) (0)
Combination Therapies (0)
Seizures (0)
Symptomatic treatments (Pharmacological Interventions) (10)
Spasticity (1)
Benzodiazepine (0)
Botulinum toxin (0)
Muscle relaxant (0)
Ataxia/Tremor (1)
Botulinum Toxin (0)
Clonazepam (0)
Gabapentin (0)
Primidone (0)
Bowel problems (0)
Depression/Anxiety/Insomnia (1)
Benzodiazepine (0)
Monoamine Oxidase Inhibitor (MAOI) (0)
Other pharmacological interventions (1)
Pharmacologic treatment of depression in multiple sclerosis (protocol stage)
Selective Serotonin Reuptake Inhibitor (SSRI) (0)
Tricyclic antidepressant (0)
Urinary problems (1)
Imipramine (0)
Propantheline (0)
Urinary tract infections (UTI) (0)
Cannabinoids (1)
Cannabinoids for multiple sclerosis (protocol stage)
Dizziness and Vertigo (0)
Dimenhydrinate (0)
Diphenhydramine (0)
Meclizine (0)
Prochlorperazine (0)
Scopolamine (0)
Fatigue (2)
Carnitine (1)
Carnitine for fatigue in multiple sclerosis (protocol stage)
Fluoxetine (0)
Modafinil (0)
Pemoline (0)
Pain and Dysaesthesia (1)
Amitriptyline (0)
Carbamazepine (0)
Desipramine (0)
Doxepin (0)
Gabapentin (0)
Imipramine (0)
Comparison of different interventions (1)
Treatment of neuropathic pain for multiple sclerosis (protocol stage)
Phentoin (0)
Protriptyline (0)
Topiramate (0)
Ziconotide (0)
Zonisamide (0)
Sexual dysfunctions (1)
Sildenafil (0)
Non pharmacological interventions (7)
Alternative therapies (i.e. acupuncture) (0)
Rehabilitation (4)
Surgery (0)
Palliative Care (0)
Health services (0)
Comparison of intervention modalities (inpatient, outpatient, day-hospital, home treatment) (0)
Delivery of care (0)
Information provision to patients and caregivers (0)
Physical and transportation barriers (0)
Preventive health care (services) (0)
Falls (0)
Rehabilitation services (0)
Outcome Measures (0)
Clinical outcomes and natural history (0)
Immunological-devised outcomes (0)
Resonance Imaging-devised outcomes (0)
Treatment of co-morbid conditions (0)
|